Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -99.67% is 56% below its 5-year average of -63.91%, near the high end of its 5-year range (-485.15%–-25.71%).
As of the fiscal period ended Tuesday, June 30, 2026. 44.32% below its 12-month average of -69.06%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -99.67%.
RETURN ON EQUITY (ROE)
-99.67%
RETURN ON EQUITY (ROE) AVG TTM
-69.06%
RETURN ON EQUITY (ROE) AVG 3Y
-89.69%
RETURN ON EQUITY (ROE) AVG 5Y
-63.91%
RETURN ON EQUITY (ROE) AVG 10Y
-97.03%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-44.32%
CURRENT VS 3Y AVG
-11.12%
CURRENT VS 5Y AVG
-55.95%
CURRENT VS 10Y AVG
-2.72%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-137.25%
vs the sector median at left
Corbus Pharmaceuticals Holdings, Inc.
Market Cap
$107.09M
Return on Equity (ROE)
-99.67%
TTM Avg
-69.06%
3Y Avg
-89.69%
5Y Avg
-63.91%
Market Cap
$107.17M
Return on Equity (ROE)
-80.97%
TTM Avg
-121.11%
3Y Avg
-93.50%
5Y Avg
-70.15%
Market Cap
$106.98M
Return on Equity (ROE)
-60.82%
TTM Avg
-19.88%
3Y Avg
-19.08%
5Y Avg
-15.27%
Market Cap
$106.96M
Return on Equity (ROE)
N/A
TTM Avg
148.53%
3Y Avg
-12.61%
5Y Avg
-408.56%
Market Cap
$106.93M
Return on Equity (ROE)
-138.73%
TTM Avg
-151.26%
3Y Avg
-114.36%
5Y Avg
-241.91%
Market Cap
$106.52M
Return on Equity (ROE)
-87.45%
TTM Avg
455.42%
3Y Avg
120.34%
5Y Avg
63.42%
Market Cap
$109.14M
Return on Equity (ROE)
N/A
TTM Avg
326.93%
3Y Avg
83.50%
5Y Avg
24.39%
Market Cap
$104.68M
Return on Equity (ROE)
-62.61%
TTM Avg
-420.52%
3Y Avg
-378.99%
5Y Avg
-378.99%
Market Cap
$104.26M
Return on Equity (ROE)
-116.28%
TTM Avg
-71.19%
3Y Avg
-41.66%
5Y Avg
-29.50%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | $107.09M | -99.67% | -69.06% | -89.69% | -63.91% |
| Apyx Medical Corporation (APYX)vs › | $107.17M | -80.97% | -121.11% | -93.50% | -70.15% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.98M | -60.82% | -19.88% | -19.08% | -15.27% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $106.96M | N/A | 148.53% | -12.61% | -408.56% |
| Vivani Medical, Inc. (VANI)vs › | $106.93M | -138.73% | -151.26% | -114.36% | -241.91% |
| Immunic, Inc. (IMUX)vs › | $106.52M | -87.45% | 455.42% | 120.34% | 63.42% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $109.14M | N/A | 326.93% | 83.50% | 24.39% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | -62.61% | -420.52% | -378.99% | -378.99% |
| Definitive Healthcare Corp. (DH)vs › | $104.26M | -116.28% | -71.19% | -41.66% | -29.50% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $110.30M | -93.44% | -8.16% | 13.24% | 13.24% |
ROE
-99.7%
ROA
-80.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -99.67% |
| 2026-03-31 | -66.90% |
| 2025-12-31 | -53.24% |
| 2025-09-30 | -73.27% |
| 2025-06-30 | -52.21% |
| 2025-03-31 | -39.56% |
| 2024-12-31 | -28.23% |
| 2024-09-30 | -25.71% |
| 2024-06-30 | -27.86% |
| 2024-03-31 | -34.81% |
| 2023-06-30 | -485.15% |
| 2023-03-31 | -307.76% |
| 2022-12-31 | -128.36% |
| 2022-09-30 | -99.48% |
| 2022-06-30 | -71.00% |
| 2022-03-31 | -63.79% |
| 2021-12-31 | -66.04% |
| 2021-09-30 | -56.67% |
| 2021-06-30 | -99.68% |
| 2021-03-31 | -106.73% |
| 2020-12-31 | -245.76% |
| 2020-09-30 | -442.21% |
| 2020-06-30 | -237.81% |
| 2020-03-31 | -329.97% |
| 2019-09-30 | -209.78% |
| 2019-06-30 | -118.19% |
| 2019-03-31 | -165.98% |
| 2018-12-31 | -202.27% |
| 2018-09-30 | -114.44% |
| 2018-06-30 | -74.66% |
| 2018-03-31 | -55.92% |
| 2017-12-31 | -56.11% |
| 2017-09-30 | -91.61% |
| 2017-06-30 | -73.64% |
| 2017-03-31 | -56.38% |
| 2016-12-31 | -224.22% |
| 2016-09-30 | -112.11% |
| 2016-06-30 | -67.04% |
| 2016-03-31 | -159.39% |
| 2015-12-31 | -98.51% |
| 2015-09-30 | -68.13% |
| 2015-06-30 | -88.91% |
| 2015-03-31 | -84.41% |
| 2014-12-31 | -43.33% |
| 2014-09-30 | -22.38% |
| 2014-06-30 | -13.02% |
